Oncolytics Biotech Reports Data in Colorectal Cancer Study
By Karen Roman Oncolytics Biotech Inc. (Nasdaq: ONCY) said it has new data showing the use of pelareorep in metastatic colorectal cancer has a 19.5-month median...
GTS Head of NYSE Listings Murphy on Market Recovery at IPO Edge Going-Public Bootcamp
The recent market turmoil has put much of the IPO market in limbo. But...
ICR Head of Special Situations Denning on Importance of Equity Story at IPO Edge Going-Public Bootcamp
The recent market turmoil has put much of the IPO market in limbo. But...
Morrow Sodali Director Dooley Explains Retail Investor Impact on SPACs at IPO Edge Going-Public Bootcamp
The recent market turmoil has put much of the IPO market in limbo. But...
Stifel Managing Director DeDomenico on Flexibility in Planning to Re-Enter the Markets at IPO Edge Going-Public Bootcamp
The recent market turmoil has put much of the IPO market in limbo. But...
Vinson & Elkins Partner Morgan on Returning Market Windows at IPO Edge Going-Public Bootcamp
The recent market turmoil has put much of the IPO market in limbo. But...
Experiential Hospitality Brand Selina Announces 11 New Openings and Locations Ahead of Public Listing
Selina is merging with BOA Acquisition Corp. By Alan Hatfield Fast-growing Millennial and Gen Z-focused...
Video Highlights – IPO Edge Going-Public Boot Camp with Nasdaq, Gallagher, Vinson & Elkins, Stifel, ICR, GTS, Morrow Sodali
The recent market turmoil has put much of the IPO market in limbo. But...
